We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.4B
AUM Growth
+$476M
Cap. Flow
-$300M
Cap. Flow %
-2.64%
Top 10 Hldgs %
22.33%
Holding
2,538
New
224
Increased
309
Reduced
1,136
Closed
102

Top Sells

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$20.7M
2
AAPL icon
Apple
AAPL
+$16M
3
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$15.6M
4
MSFT icon
Microsoft
MSFT
+$13M
5
WMB icon
Williams Companies
WMB
+$9.28M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Financials 13.29%
3 Healthcare 12.64%
4 Consumer Discretionary 11.46%
5 Industrials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOFG
2226
DELISTED
MidWestOne Financial Group
MOFG
$181K ﹤0.01%
6,292
RIGL icon
2227
Rigel Pharmaceuticals
RIGL
$782M
$181K ﹤0.01%
4,170
-2,763
-40% -$104K
MRC
2228
DELISTED
MRC Global
MRC
$181K ﹤0.01%
19,224
-11,432
-37% -$116K
INNV icon
2229
InnovAge Holding
INNV
$1.42B
$181K ﹤0.01%
+8,476
New +$194K
KBAL
2230
DELISTED
Kimball International
KBAL
$180K ﹤0.01%
13,705
+7,088
+107% +$96.6K
FUV
2231
DELISTED
Arcimoto, Inc. Common Stock
FUV
$180K ﹤0.01%
+523
New +$121K
MPAA icon
2232
Motorcar Parts of America
MPAA
$230M
$180K ﹤0.01%
8,000
VPG icon
2233
Vishay Precision Group
VPG
$934M
$179K ﹤0.01%
5,267
ARR
2234
Armour Residential REIT
ARR
$2.36B
$179K ﹤0.01%
3,139
-2,064
-40% -$124K
ALNT icon
2235
Allient
ALNT
$1.94B
$179K ﹤0.01%
5,181
CTXR icon
2236
Citius Pharmaceuticals
CTXR
$21M
$178K ﹤0.01%
+2,046
New +$123K
GTBP icon
2237
GT Biopharma
GTBP
$10.9M
$178K ﹤0.01%
+382
New +$159K
KDNY
2238
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$177K ﹤0.01%
+12,517
New +$200K
SFST icon
2239
Southern First Bancshares
SFST
$607M
$176K ﹤0.01%
3,434
BXC icon
2240
BlueLinx
BXC
$701M
$175K ﹤0.01%
+3,473
New +$171K
ATRS
2241
DELISTED
Antares Pharma, Inc.
ATRS
$173K ﹤0.01%
39,757
-27,056
-40% -$110K
CONN
2242
DELISTED
Conn's Inc.
CONN
$172K ﹤0.01%
+6,760
New +$156K
MMAT
2243
DELISTED
Meta Materials Inc. Common Stock
MMAT
$172K ﹤0.01%
+230
New +$128K
WLDN icon
2244
Willdan Group
WLDN
$1.29B
$172K ﹤0.01%
4,570
BRY
2245
DELISTED
Berry Corp
BRY
$172K ﹤0.01%
25,579
+18,328
+253% +$116K
HCKT icon
2246
Hackett Group
HCKT
$278M
$171K ﹤0.01%
9,515
+5,712
+150% +$99.3K
DX
2247
Dynex Capital
DX
$3.22B
$171K ﹤0.01%
9,188
AKTS
2248
DELISTED
Akoustis Technologies Inc
AKTS
$171K ﹤0.01%
15,978
+11,598
+265% +$123K
SPRY icon
2249
ARS Pharmaceuticals
SPRY
$601M
$171K ﹤0.01%
5,527
BLBD icon
2250
Blue Bird Corp
BLBD
$2.04B
$171K ﹤0.01%
6,865

Similar funds

MetLife Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, MetLife Investment Management held 2,538 positions worth $11.4B, up 4.4% from $10.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management's Q2 2021 filing shows 224 new, 309 increased, 1,136 reduced and 102 closed positions. Its largest new stake was UiPath: 142,126 shares worth $9.65M. The largest sale was MPLX, an estimated $20.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q2 2021 buy was UiPath: 142,126 shares worth $9.65M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $24.1M increase.
  • MetLife Investment Management's biggest Q2 2021 reduction was Apple, cutting an estimated $16M.
  • MetLife Investment Management fully exited MPLX in Q2 2021, selling an estimated $20.7M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $11.4B portfolio in Q2 2021.
  • MetLife Investment Management opened 224 new positions and closed 102 in Q2 2021.
  • MetLife Investment Management's portfolio value rose 4.4% quarter-over-quarter to $11.4B.

Based on MetLife Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.